Cargando…
High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
INTRODUCTION: Pre-exposure prophylaxis (PrEP) may be an important safer conception strategy for HIV-1–uninfected women with HIV-1–infected partners. Understanding medication adherence in this population may inform whether PrEP is a feasible safer conception strategy. METHODS: We evaluated predictors...
Autores principales: | Matthews, Lynn T., Heffron, Renee, Mugo, Nelly R., Cohen, Craig R., Hendrix, Craig W., Celum, Connie, Bangsberg, David R., Baeten, Jared M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149628/ https://www.ncbi.nlm.nih.gov/pubmed/25118795 http://dx.doi.org/10.1097/QAI.0000000000000246 |
Ejemplares similares
-
HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014) -
Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study
por: Roberts, Sarah T., et al.
Publicado: (2016) -
Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption
por: Mugwanya, Kenneth K., et al.
Publicado: (2016) -
Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017) -
Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)